Steel Partners has made an unsolicited cash acquisition proposal for InMode at $16.75 per share, valuing the company at approximately $1.1 billion. InMode, a leading manufacturer of RF microneedling, monopolar RF, and other energy-based aesthetic devices, confirmed receipt of the proposal and initiated a formal review process. The stock initially surged on the bid announcement.
Business & M&A
Steel Partners Bids $16.75 Per Share for InMode — What a Takeover Means for Device Buyers
The PE firm's unsolicited offer values the RF and energy-device maker at roughly $1.1B, triggering shareholder and board review.
1-YEAR MOVE
INMD▲1.0%
| Ticker | Company | 1-year change |
|---|---|---|
| INMD | InMode Ltd. | +1.0% |
$16.75 per share cash offer values InMode at roughly $1.1B.
For practice owners, a Steel Partners acquisition would likely reshape InMode's go-to-market strategy and pricing. Steel Partners typically pursues operational efficiency and cash extraction post-close, which could mean higher device costs, reduced rebate programs, or tighter financing terms. InMode's current Alle loyalty program and direct-to-practice relationships might face restructuring. The outcome hinges on whether InMode's board accepts, seeks alternative bidders, or negotiates a higher price. Practices should monitor the deal timeline and any changes to device acquisition economics.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.